{"id":312669,"date":"2010-02-12T15:52:51","date_gmt":"2010-02-12T20:52:51","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=63263"},"modified":"2010-02-12T15:52:51","modified_gmt":"2010-02-12T20:52:51","slug":"140m-for-new-mpm-bioventures-fund","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/312669","title":{"rendered":"$140M for New MPM BioVentures Fund"},"content":{"rendered":"\n
deals<\/a>, funding<\/a>, Life Sciences<\/a><\/div>\n

\t\tErin Kutz wrote:<\/strong><\/p>\n

Boston-based MPM Capital<\/a>, an investment firm focused on life sciences companies, has raised $140 million for its fifth BioVentures fund, according to regulatory filings<\/a>. Earlier reports pegged the deal at $69.1 million, but the company amended its original filing<\/a> this afternoon to indicate the higher total. The firm declined to comment further on the new funding. MPM’s $552 million BioVentures IV fund<\/a> led a $35 million series B round at the end of January for Alnara Pharmaceuticals, a Cambridge, MA, developer of protein-based treatments for metabolic diseases.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

deals, funding, Life Sciences Erin Kutz wrote: Boston-based MPM Capital, an investment firm focused on life sciences companies, has raised $140 million for its fifth BioVentures fund, according to regulatory filings. Earlier reports pegged the deal at $69.1 million, but the company amended its original filing this afternoon to indicate the higher total. The firm […]<\/p>\n","protected":false},"author":1661,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-312669","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/312669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1661"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=312669"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/312669\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=312669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=312669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=312669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}